HER2-positive breast cancer vaccine (trial)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2-positive breast cancer vaccine (trial), covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer [Phase 2]